← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,486개
ADCBiologicstaleBolt Biotherapeutics, Inc.Phase 2

BDC-4182 (BDC-4182)

Gastric Cancer Adenocarcinoma Metastatic; Gastroesophageal Adenocarcinoma · Gastric Cancer Adenocarcinoma Metastatic

#GastricCancerAdenocarcinomaMetas#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleBigHat Biosciences, Inc.Phase 2

BHB810 (BHB810)

Gastric Cancer; Gastric Adenocarcinoma · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleBiOneCure Therapeutics Inc.Phase 2

BIO-106 (BIO-106)

Advanced Cancer; Advanced Solid Tumor · Advanced Cancer

#AdvancedCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleM.D. Anderson Cancer CenterPhase 2

Relatlimab-Nivolumab FDC (BMS-986213, BMS-986213 (Relatlimab-Nivolumab FDC))

Melanoma (Skin) · Melanoma (Skin)

#MelanomaSkin#Antibody#Phase2#항체#면역항체+2
효능 ORR 61.9%임상시험 1상태 RECRUITING
AntibodystaleBristol-Myers SquibbPhase 3

BMS-986012+Nivolumab (BMS-986489, BMS-986489 (BMS-986012+Nivolumab))

Extensive-Stage Small Cell Lung Cancer · Extensive-Stage Small Cell Lung Cancer

#Extensive-StageSmallCellLungCanc#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 1

BNT116 (BNT116)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 1

BNT316 (BNT316)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 2

BNT323 (BNT323)

Locally Advanced Breast Cancer; Unresectable Breast Carcinoma · Locally Advanced Breast Cancer

#LocallyAdvancedBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 3

BNT323/DB-1303 (BNT323/DB-1303)

Endometrial Cancer · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 2

BNT329 (BNT329)

Advanced Solid Cancers · Advanced Solid Cancers

#AdvancedSolidCancers#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleHighlight TherapeuticsPhase 2

pembrolizumab (Keytruda, BO-112 with pembrolizumab)

Colorectal Cancer; Gastric Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 0%임상시험 1상태 DISCONTINUED
AntibodystaleBioXcel Therapeutics IncPhase 2

pembrolizumab (Keytruda, BXCL701 plus Pembrolizumab)

Prostate Cancer; Neuroendocrine Tumors · Prostate Cancer

#ProstateCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleYuan YuanPhase 2

Balstilmab (Balstilmab)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Triple-Negative Breast Carcinoma · Anatomic Stage IV Breast Cancer AJCC v8

#AnatomicStageIVBreastCancerAJCCv#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCBiologicstaleChildren's Cancer Group, ChinaPhase 3

Bedamustine (Bedamustine)

Classical Hodgkin Lymphoma; Child · Classical Hodgkin Lymphoma

#ClassicalHodgkinLymphoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

Benmelstobart (Benmelstobart)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleNational Cancer Institute (NCI)Phase 2

Berzosertib (Berzosertib)

HRD Cancer; SCLC · HRD Cancer

#HRDCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodyBiologicstaleRochePhase 1

aka Avastin or Rhu MAb VEGF (Bevacizumab, Bevacizumab (aka Avastin or Rhu MAb VEGF))

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

and approved biosimilars (Bevacizumab, Bevacizumab (and approved biosimilars))

Solid Tumor; Colorectal Cancer · Solid Tumor

#SolidTumor#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Bevacizumab, Bevacizumab (drug), Herceptin (drug), drug)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 73%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab + Capecitabine + Radiotherapy (Bevacizumab + Capecitabine + Radiotherapy)

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

34 / 75 페이지

← 이전다음 →